Insider · CIK 0001270734

PAKIANATHAN DEEPIKA

Reports to the SEC for 14 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001270734

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−58.1K sh	—	—	6,009
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,009 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.6K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.4K sh	—	—	0
2026-06-12	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,009 sh	—	—	64,074
2026-06-12	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,398
2026-05-21	KPTIKaryopharm Therapeutics Inc.A Award	Director	AAward	+15.5K sh	—	—	15,508
2026-02-26	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	Director	AAward	+66K sh	—	—	66,000
2025-05-28	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+4,600 sh	—	—	4,600
2025-05-19	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.6K sh	—	—	58,065
2025-05-19	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,258
2025-02-05	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+1,825 sh	$3.00	+$5,475	1,825
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+6,492 sh	$1.84	+$11.9K	8,317
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+12.4K sh	$2.72	+$33.8K	20,735
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+39K sh	$1.31	+$51K	59,688
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+43.5K sh	$0.94	+$40.9K	103,173
2024-08-22	MREOMereo BioPharma Group plcM Exercise/Conversion	Director	MExercise/Conversion	+2,071 sh	$3.87	+$8,014.77	105,244
2024-08-22	MREOMereo BioPharma Group plcS Sale	Director	SSale	−105K sh	$4.43	−$466K	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,500 sh	—	—	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−31.5K sh	—	—	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−55K sh	—	—	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−55K sh	—	—	0
2024-08-22	MREOMereo BioPharma Group plc · Share Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	30,000
2024-06-07	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−229K sh	$0.95	−$218K	0
2024-06-07	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−2,240 sh	$0.95	−$2,129.568	0
2024-06-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−117K sh	$0.98	−$115K	229,308
2024-06-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−1,145 sh	$0.98	−$1,125.306	2,240
2024-06-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−464K sh	$0.96	−$444K	346,615
2024-06-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−4,526 sh	$0.96	−$4,336.813	3,385
2024-06-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−338K sh	$0.95	−$322K	810,133
2024-06-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−3,298 sh	$0.95	−$3,140.026	7,911
2024-06-03	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−357K sh	$1.00	−$358K	1,147,875
2024-06-03	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−3,488 sh	$1.00	−$3,490.442	11,209
2024-05-31	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−202K sh	$0.95	−$193K	1,505,131
2024-05-31	KPTIKaryopharm Therapeutics Inc.S Sale	Director	SSale	−1,976 sh	$0.95	−$1,885.104	14,697
2024-05-29	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+69K sh	—	—	69,000
2024-05-08	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.5K sh	—	—	47,416
2024-05-08	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+23.6K sh	—	—	23,576
2024-02-08	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2023-05-24	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-05-02	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,132 sh	—	—	36,879
2023-05-02	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,044
2023-01-27	Calithera Biosciences, Inc.S Sale	Director	SSale	−120K sh	$0.39	−$46.4K	0

Recent filings

Accepted (ET)
Sep 244
PAKIANATHAN DEEPIKA0001270734-26-000007
SEC(opens sec.gov)
Jun 164
PAKIANATHAN DEEPIKA0001270734-26-000004
SEC(opens sec.gov)
May 264
PAKIANATHAN DEEPIKA0001270734-26-000002
SEC(opens sec.gov)
Feb 274
PAKIANATHAN DEEPIKA0001193125-26-082818
SEC(opens sec.gov)
May 294
PAKIANATHAN DEEPIKA0000950170-25-078961
SEC(opens sec.gov)
May 214
PAKIANATHAN DEEPIKA0001415889-25-014022
SEC(opens sec.gov)
Feb 64
PAKIANATHAN DEEPIKA0000950170-25-015423
SEC(opens sec.gov)
Aug 234
PAKIANATHAN DEEPIKA0000950170-24-100281
SEC(opens sec.gov)

Companies

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080